Due to COVID-19, new enrollment in research studies will be greatly limited.
If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry.
View the guidance for research participants for additional information.
This study enrolls children younger than 19 who are in the Pediatric Intensive Care Unit (ICU) with kidney injury and have tested positive or are being investigated for COVID-19. The purpose of this study is to see the number of children with kidney injury and its association with COVID-19. Read More
People under age 19
Receiving care in the Pediatric ICU between April 1 2020 and June 30 2020
Suspected or tested positive for COVID19
This study enrolls people who have been diagnosed with Tricuspid Regurgitation (TR) and have Heart Failure symptoms which are not under control despite treatment with current available therapies. The purpose of this study is to compare a new investigational (experimental) device plus optimal drug therapy with optimal drug therapy alone. Read More
Adults ages 18+
Diagnosed with moderate or greater Tricuspid Regurgitation/Insufficiency with Heart Failure symptoms
This study enrolls children less than 19 years old who are admitted to the Pediatric ICU and have tested positive for SARS-CoV2. The purpose of this study is to better understand the number of children who are in severe/critical care units due to COVID-19, risk factors, and factors that are associated with improved or worsening outcomes. Read More
Children ages 19 and under
Admitted to the Pediatric ICU or receiving treatment for severe case of COVID-19
Considered to have severe case of COVID-19
This study enrolls patients with a spinal cord injury (SCI) or their caregiver. The purpose of this study is to determine if the community-based summer camp called EmpowerSCI can help patients who have finished in-hospital rehabilitation, by further benefiting their short-term and long-term abilities in daily activities. Read More
People with spinal cord injuries (SCI) or their caregivers
This study enrolls people who have been diagnosed with Idiopathic Intracranial Hypertension (IIH), or high pressure in the brain due to unknown reasons. The purpose of this study is to find out if an investigational (experimental) device, which has not been approved by the FDA yet, is safe and can help treat patients who suffer from vision problems and headaches related to IIH. The device being tested is a stent that will reopen the narrowed veins in the brain as other small studies have shown this to be beneficial to patients with IIH. Read More
People ages 18+
Diagnosis of IIH with symptoms of headaches or vision problems
The purpose of this research study is to compare the use of apixaban to aspirin in patients with unexplained strokes and atrial cardiopathy to see which is better at prevention of future strokes. Read More
Adults ages 45+
Have been diagnosed with an ischemic stroke of undetermined cause in the last 120 days.
Currently admitted to Gates Vascular Institute.
This study enrolls patients who are diagnosed with COVID-19 or who may have it and are admitted to the hospital. The purpose of this study is to create a real-time database of patients with COVID-19 to help collect data to see if our safety practices are effective and to compare our practices with other hospitals. All data collected will have patient information removed. Read More
All patients with COVID-19 PCR positive (within 7 days)/PCR pending/high clinical suspicion admitted to VIRUS study participating hospital will be eligible.
1. COVID-19 PCR positive (within 7 days)
2. COVID-19 PCR pending
3. COVID-19 high clinical suspicion
This study enrolls people who are being tested for COVID-19 by order from their doctor or the Department of Health. The purpose of this study is to find a relationship between potential signs and symptoms of COVID-19 and those who receive a positive test result. These results will help local medical professionals better understand symptoms and how COVID-19 testing is working in our community. Read More
People age 18+
People who were ordered to get COVID19 testing by their doctor or Department of Health
Not hospitalized due to symptoms